A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to antimicrobial agents.
Donati M., Di Francesco A., D’Antuono A., Delucca F., Shurdhi A., Moroni A., et al. (2010). In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 54, 5379-5380 [10.1128/AAC.00553-10].
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
DONATI, MANUELA;DI FRANCESCO, ANTONIETTA;D'ANTUONO, ANTONIETTA;SHURDHI, ALISA;BALDELLI, RAFFAELLA;CEVENINI, ROBERTO
2010
Abstract
A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to antimicrobial agents.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
